Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 43(1); 2022 > Article
Lee, Choi, Noh, Min, and Kim: East Asian Herbal Medicine (EAHM) Alone for the Treatment of Women with Diminished Ovarian Reserve (DOR): A Systematic Review and Meta-analysis

Abstract

Objectives

The aim of this study was to find out whether east asian herbal medicine (EAHM) treatment alone is effective in improving pregnancy-related indicators compared to conventional medicine in women with Diminished Ovarian Reserve (DOR).

Methods

We searched eligible studies from PubMed, Cochrane Library, EMBASE, Chinese National Knowledge Infrastructure Database, CiNii, Korean Medical Database, Korean Studies Information Service System, Oriental Medicine Advanced Searching Integrated System, ScienceOn. GRADE pro was used to evaluate the current evidence of the study.

Result

A total of 5 studies, 325 women with DOR were included. EAHM showed a significant effect on improvement of pregnancy rate (n=270, RR 2.13 [95% CI 1.44 to 3.15], Z=3.78, p=0.0002, I2=0%) and Anti-Mullerian Hormone (AMH) level (n=211, SMD 0.82 [95% CI 0.40 to 1.25], Z=3.80, p=0.0001) compared to conventional medicine. In ovulation rate (n=156, RR 0.86 [95% CI 0.70 to 1.06], Z=1.43, p=0.15, I2=0%), Antral Follicle Count (n=245, SMD 0.27 [95% CI −0.25 to 0.79], Z=1.01, p=0.31), and follicle stimulating hormone (n=245, SMD 0.29 [95% CI −0.13 to 0.70], Z=1.36, p=0.17) level, EAHM showed similar effects to conventional medicine. In this study, the most frequently used herbal medicines were Cuscutae Semen, Dipsaci Radix, and Angelicae Gigantis Radix.

Conclusion

This meta-analysis showed that EAHM could improve pregnancy rates and AMH levels in women with DOR. However, more well-designed RCTs will have to be performed further in the future.

Fig. 1
The PRISMA Flow Diagram of Study Selection
jkm-43-1-136f1.gif
Fig. 2
Summary of Risk of Bias in All Included Studies
jkm-43-1-136f2.gif
Fig. 3
Forest Plot of Pregnancy Rate
jkm-43-1-136f3.gif
Fig. 4
Forest Plot of Secondary Outcome (a) Ovulation Rate (b) Anti-Mullerian Hormone (c) Antral Follicle Count (d) Follicle Stimulating Hormone (e) Ovarian Volume
jkm-43-1-136f4.gif
Table 1
Summary of the Studies Included
Included study
Study year
Country
Types of infertility Trial design Number of participants; Age(mean+SD, years) Interventions Course of treatment; Follow up period Outcome measures Intergroup differences
Trial Control Trial Control
Wang 201211)
China
DOR RCT 17
37.53, 35–42y
17
38.00, 35–42y
Xianziyizhen No1 3 capsules, No2 4 capsules tid DHEA 25mg tid 3 menstrual cycle period
3months
  1. Pregnancy rate

  2. AMH

  3. AFC

  4. FSH

  1. p>0.05

  2. NR

  3. p>0.05

  4. p>0.05

Guan 201612)
China
DOR RCT 30
24–49y
25
24–49y
kidney and liver blood chinese traditional medicine oral granule bid estradiol valerate (Climen) qd 3 menstrual cycle period
NR
  1. AMH

  2. AFC

  3. FSH

  4. ovarian volume

  1. p<0.05

  2. p<0.05

  3. p>0.05

  4. p>0.05

Wang 202013)
China
DOR RCT 30
20–40y
26
20–40y
Bushen Culuan Formula Decoction 250ml qd estradiol valerate (Climen), Clomiphene qd 3 menstrual cycle period
3months
  1. Pregnancy rate

  2. Ovulation rate

  3. AMH

  4. AFC

  5. FSH

  1. p>0.05

  2. p>0.05

  3. p>0.05

  4. p<0.05

  5. p<0.05

Duan 202114)
China
DOR RCT 40
33.4, 21–39y
40
32.8, 20–39y
Zhuyun Tang Granule, Guchong Tang Granule qd estradiol valerate qd, Dydrogesterone bid 3 menstrual cycle period
1year
  1. Pregnancy rate

  2. AMH

  3. AFC

  4. FSH

  1. NR

  2. p<0.001

  3. p<0.001

  4. p<0.001

Ma 202115) China DOR RCT 50
34.18±3.91
50
33.50±4.16
Bushen Huoxue Culuan Formula Decoction 200ml bid estradiol valerate (Climen), Clomiphene bid 3 menstrual cycle period
2years
  1. Pregnancy rate

  2. Ovulation rate

  3. AMH

  4. AFC

  5. FSH

  1. p<0.05

  2. p<0.05

  3. p<0.05

  4. p>0.05

  5. p<0.05

DOR: Diminished Ovarian Reserve ; RCT: Randomized Clinical Trial ; DHEA: Dehydroepiandrosterone ; AMH: Anti-Mullerian Hormone ; AFC: Antral Follicle Count : FSH: Follicle Stimulating Hormone ; NR: Non Reported

Table 2
Summary of Finding
Intervention and comparator intervention Outcomes Participants (n) (studies) Relative effect (95% CI) Anticipated absolute effects: Risk difference with EAHM Heterogeneity (I2, p) Quality of the evidence
EAHM alone vs Conventional medicine Pregnancy rate 270 (4 RCTs) RR 2.13 [1.44, 3.15] 221 more per 1,000 (from 86 more to 420 more) I2=0%, p=0.84 ⊕⊕⊕⊕
High
Pregnancy success rate 100 (1 RCT) RR 6.25 [2.35, 16.65] 420 more per 1,000 (from 108 more to 1000 more) - ⊕○○○
Very low
Ovulation rate 156 (2 RCTs) RR 0.86 [0.70, 1.06] 105 fewer per 1,000 (from 225 fewer to 45 more) I2=0%, p=0.54 ⊕⊕⊕⊕
High
AMH 211 (3 RCTs) - SMD 0.82 higher (0.4 higher to 1.25 higher) I2=53%, p=0.12 ⊕○○○
Very low
AFC 245 (4 RCTs) - SMD 0.27 higher (0.25 lower to 0.79 higher) I2=74%, p=0.008 ⊕○○○
Very low
FSH 245 (4 RCTs) - SMD 0.3 higher (0.12 lower to 0.71 higher) I2=60%, p=0.06 ⊕○○○
Very low
Ovarian volume 55 (1 RCT) - SMD 0.48 lower (1.02 lower to 0.06 higher) - ⊕⊕○○
Low

EAHM: East Asian Herbal Medicine, AMH: Anti-Mullerian Hormone, AFC: Antral Follicle Count, FSH: Follicle Stimulating Hormone, CI: confidence interval; RR: risk ratio; SMD: standardized mean difference

Table 3
Ingredients of EAHM used in clinical trials
References EAHM prescription name Ingredients of herb prescription (Latin name) Ingredients of EAHM prescription (scientific name) Types of preparation
Wang 201211) Xianziyizhen No.1 Morindae Radix, Epimedii Herba, Angelicae Gigantis Radix, Lycii Fructus, Dipsaci Radix, Astragali Radix Morinda officinalis How, Epimedium koreanum Nakai, Angelica gigas Nakai, Lycium chinense Miller, Dipsacus asperoides C. Y. Cheng et T. M. Ai, Astragalus membranaceus Bunge Capsule
Xianziyizhen No.2 Rehmanniae Radix Preparata, Ligustri Fructus, Ecliptae Herba, Dipsaci Radix, Cuscutae Semen, Epimedii Herba, Rehmannia glutinosa Liboschitz ex Steudel,, Ligustrum japonicum Thunb., Eclipta prostrata Linné, Dipsacus asperoides C. Y. Cheng et T. M. Ai, Cuscuta chinensis Lamark, Epimedium koreanum Nakai Capsule
Guan 201612) Bushen Shugan Yangxue Recipe Cuscutae Semen, Rehmanniae Radix Preparata, Uncariae Ramulus cum Uncus, Curcumae Radix, Dipsaci Radix, Cyperi Rhizoma, Angelicae Gigantis Radix, -, Spatholobi Caulis, Salviae Miltiorrhizae Radix, Rosae Rugosae Flos, Hordei Fructus Germinatus Cuscuta chinensis Lamark, Rehmannia glutinosa Liboschitz ex Steudel, Uncaria sinensis Havil, Curcuma longa Linné, Dipsacus asperoides C. Y. Cheng et T. M. Ai, Cyperus rotundus Linné, Angelica gigas Nakai, Rhodiola rosea L., Spatholobus suberectus Dunn, Salvia miltiorrhiza Bunge, Rosa rugosa Thunberg, Hordeum vulgare Linné var. hexastichon Aschers Granule
Wang 202013) Bushen Culuan Formula Cuscutae Semen, Ligustri Fructus, Lycii Fructus, Loranthi Ramulus Et Folium, Dipsaci Radix, Achyranthis Radix, Angelicae Gigantis Radix, Paeoniae Radix, Lycopi Herba, Typhae Pollen, Salviae Miltiorrhizae Radix, Cyperi Rhizoma, Cuscuta chinensis Lamark, Ligustrum japonicum Thunb., Lycium chinense Miller, Loranthus parasticus Merr., Dipsacus asperoides C. Y. Cheng et T. M. Ai, Achyranthes japonica Nakai, Angelica gigas Nakai, Paeonia lactiflora Pallas, Lycopus lucidus Turczaininov, Typha orientalis Presl, Salvia miltiorrhiza Bunge, Cyperus rotundus Linné Decoction
Duan 202114) Zhuyun Tang Cuscutae Semen, Lycii Fructus, Rubi Fructus, Morindae Radix, Epimedii Herba, Cervi Parvum Cornu, Dipsaci Radix, Eucommiae Cortex, Mori Fructus, Polygoni Multiflori Radix, Fluoritum, Araliae Continentalis Radix Cuscuta chinensis Lamark, Lycium chinense Miller, Rubus coreanus Miquel, Morinda officinalis How, Epimedium koreanum Nakai, Cervus canadensis, Dipsacus asperoides C. Y. Cheng et T. M. Ai, Eucommia ulmoides Oliver, Morus alba Linné, Polygonum multiflorum Thunberg, -, Aralia continentalis Kitagawa Granule
Guchong Tang Cuscutae Semen, Lycii Fructus, Rubi Fructus, Morindae Radix, Epimedii Herba, Cervi Parvum Cornu, Dipsaci Radix, Eucommiae Cortex, Ecliptae Herba, Ligustri Fructus, Dioscoreae Rhizoma, Cuscuta chinensis Lamark, Lycium chinense Miller, Rubus coreanus Miquel, Morinda officinalis How, Epimedium koreanum Nakai, Cervus canadensis, Dipsacus asperoides C. Y. Cheng et T. M. Ai, Eucommia ulmoides Oliver, Eclipta prostrata Linné, Ligustrum japonicum Thunb., Dioscorea batatas Decaisne Granule
Ma 202115) Bushen Huoxue Culuan Formula Ligustri Fructus, Cuscutae Semen, Epimedii Herba, Morindae Radix, Salviae Miltiorrhizae Radix, Angelicae Gigantis Radix, Cnidii Rhizoma, Paeoniae Radix, Lycopi Herba, Typhae Pollen, Ligustrum japonicum Thunb., Cuscuta chinensis Lamark, Epimedium koreanum Nakai, Morinda officinalis How, Salvia miltiorrhiza Bunge, Angelica gigas Nakai, Cnidium officinale Makino, Paeonia lactiflora Pallas, Lycopus lucidus Turczaininov, Typha orientalis Presl Decoction

EAHM : east asian herbal medicine; NR: not reported

Table 4
Frequency of Use of Herbs
Herb name (Latin) Frequency Amount (g)
Cuscutae Semen 4.5 12–30
Dipsaci Radix 4 10–12
Angelicae Gigantis Radix 3.5 10–15
Salviae Miltiorrhizae Radix 3 12–30
Epimedii Herba 3 10
Ligustri Fructus 3 10–20
Lycii Fructus 2.5 12–20
Morindae Radix 2.5 10–12
Cyperi Rhizoma 2 10
Lycopi Herba 2 15
Paeoniae Radix 2 15
Typhae Pollen 2 15
Rehmanniae Radix Preparata 1.5 15

참고문헌

1. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. 2005; Definition and prevalence of subfertility and infertility. Human reproduction (Oxford, England). 20:5. 1144–1147. https://doi.org/10.1093/humrep/deh870
crossref pmid

2. Statistics Korea. Regional indicators: Total fertility rate [Internet]. Daejeon: Statistics Korea;c2020. [cited 2021 Nov 26]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B81A21&vw_cd=&list_id=&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=E1&docId=0028401391&markType=S&itmNm=%EC%A0%84%EA%B5%AD


3. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, & Practice Committee of the American Society for Reproductive Medicine. 2020; Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and sterility. 114:6. 1151–1157. https://doi.org/10.1016/j.fertnstert.2020.09.134
crossref pmid

4. Mutlu MF, Erdem A. 2012; Evaluation of ovarian reserve in infertile patients. Journal of the Turkish German Gynecological Association. 13:3. 196–203. https://doi.org/10.5152/jtgga.2012.28
crossref pmid pmc

5. Yilmaz N, Uygur D, Inal H, Gorkem U, Cicek N, Mollamahmutoglu L. 2013; Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count. European journal of obstetrics, gynecology, and reproductive biology. 169:2. 257–260. https://doi.org/10.1016/j.ejogrb.2013.04.0039
crossref pmid

6. Wang Y, Wu JZ, Li Y, Qi X. 2019; Polysaccharides of Fructus corni Improve Ovarian Function in Mice with Aging-Associated Perimenopause Symptoms. Evidence-based complementary and alternative medicine : eCAM. 2019; 2089586 https://doi.org/10.1155/2019/2089586
crossref

7. Yin J, Chang HM, Li R, Leung PC. 2021; Recent progress in the treatment of women with diminished ovarian reserve. Gynecology and Obstetrics Clinical Medicine. 1:4. 186–189. https://doi.org/10.1016/j.gocm.2021.10.004
crossref

8. Liu L, Liu Y, Yang M, Xu G, Li R, Xu X, Pan X, Liang J. 2020; Effectiveness of tonifying-kidney and regulating-liver therapy on diminished ovarian reserve: a systematic review and Meta-analysis of randomized controlled trials. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 40:3. 343–354. https://doi.org/10.19852/j.cnki.jtcm.2020.03.001
pmid

9. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. 2019. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons.
crossref

10. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ. 2011; GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 64:4. 383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026
crossref pmid

11. Zhuran Wang. 2012. Clinical Research on Effect of Kidney-tonilying Traditional Chinese Herbs to Improve the Female Reproductive Potential in Late-reproductive Age. Master’s thesis. Guangzhou University of Traditional Chinese Medicine).


12. Yu Guan. 2016. Clinical Observation on Treatment of Decreased Ovarian Reserve Function by Tonifying Kidney, Soothing Liver and Nourishing Blood. Master’s thesis. Beijing University of Chinese Medicine.


13. Kaili Wang. 2020. Clinical Study of Bushen Culuan Formula Treatment for Infertility Caused by Premature Ovarian Insufficiency. Master’s thesis. China Academy of Chinese Medical Sciences.


14. Wenxu Duan, Yueyi Cheng. 2021; Sequential therapy for kidney-tonifying via traditional Chinese medicine effectively improves the reproductive potential and quality of life of women with decreased ovarian reserve: a randomized controlled study. American journal of translational research. 4.


15. Kun Ma, Jingxian Wu, Huixian Zhang, Kaili Wang, Bihui Peng. 2021; Clinical Study on Treatment of Infertility Caused by Low Ovarian Reserve Function of Kidney Deficiency and Blood Stasis Syndrome with Bushen Huoxue Huo Decoction. Chinese Journal of Traditional Chinese Medicine. 11. 2644–2649. 10.19540/j.cnki.cjcmm.20210317.502


16. Ramalho de Carvalho B, Gomes Sobrinho DB, Vieira AD, Resende MP, Barbosa AC, Silva AA, Nakagava HM. 2012; Ovarian reserve assessment for infertility investigation. ISRN obstetrics and gynecology. 2012:576385 https://doi.org/10.5402/2012/576385
crossref pmid pmc

17. Qin JC, Fan L, Qin AP. 2017; The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis. Journal of gynecology obstetrics and human reproduction. 46:1. 1–7. https://doi.org/10.1016/j.jgyn.2016.01.002
crossref pmid

18. Narkwichean A, Maalouf W, Campbell BK, Jayaprakasan K. 2013; Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reproductive biology and endocrinology : RB&E. 11:44 https://doi.org/10.1186/1477-7827-11-44
crossref

19. Klinge CM, Clark BJ, Prough RA. 2018; Dehydroepiandrosterone Research: Past, Current, and Future. Vitamins and hormones. 108:1–28. https://doi.org/10.1016/bs.vh.2018.02.002
crossref pmid

20. Mitwally MF, Casper RF. 2003; Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Human reproduction (Oxford, England). 18:8. 1588–1597. https://doi.org/10.1093/humrep/deg311
crossref pmid

21. Song D, Shi Y, Zhong Y, Meng Q, Hou S, Li H. 2016; Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\ICSI procedures: a meta-analysis. European journal of obstetrics, gynecology, and reproductive biology. 204:36–43. https://doi.org/10.1016/j.ejogrb.2016.07.498
crossref pmid

22. Bishop LA, Richter KS, Patounakis G, Andriani L, Moon K, Devine K. 2017; Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients. Fertility and sterility. 108:6. 980–987. https://doi.org/10.1016/j.fertnstert.2017.09.011
crossref pmid

23. Chang Y, Li J, Li X, Liu H, Liang X. 2018; Egg Quality and Pregnancy Outcome in Young Infertile Women with Diminished Ovarian Reserve. Medical science monitor : international medical journal of experimental and clinical research. 24:7279–7284. https://doi.org/10.12659/MSM.910410
crossref pmid pmc

24. Cao H, Han M, Ng EH, Wu X, Flower A, Lewith G, Liu JP. 2013; Can Chinese herbal medicine improve outcomes of in vitro fertilization? A systematic review and meta-analysis of randomized controlled trials. PloS one. 8:12. e81650 https://doi.org/10.1371/journal.pone.0081650
crossref pmid pmc

25. Ried K, Stuart K. 2011; Efficacy of Traditional Chinese Herbal Medicine in the management of female infertility: a systematic review. Complementary therapies in medicine. 19:6. 319–331. https://doi.org/10.1016/j.ctim.2011.09.003
crossref pmid

26. Xia T, Ma RH, Mu W, Ma SH, Mao SW, Fu Y. 2014; Traditional Chinese medicine for diminished ovarian reserve: a systematic review and meta-analysis. Chinese Herbal Medicines. 6:2. 93–102. https://doi.org/10.1016/S1674-6384(14)60014-9
crossref

27. Jang S, Kim KH, Jun JH, You S. 2020; Acupuncture for in vitro fertilization in women with poor ovarian response: a systematic review. Integrative medicine research. 9:2. 100395 https://doi.org/10.1016/j.imr.2020.02.003
crossref pmid pmc

28. Zheng Y, Feng X, Mi H, Yao Y, Zhao Y, Li J, Jiao J, Gong A, Sun W, Deng X. 2015; Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles. The journal of obstetrics and gynaecology research. 41:12. 1905–1911. https://doi.org/10.1111/jog.12810
crossref pmid

29. Romanski PA, Bortoletto P, Rosenwaks Z, Schattman GL. 2020; Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Human reproduction (Oxford, England). 35:7. 1630–1636. https://doi.org/10.1093/humrep/deaa137
crossref pmid pmc

30. Huang C, Song K, Ma W, Ding J, Chen Z, Zhang M. 2017; Immunomodulatory mechanism of Bushen Huoxue Recipe alleviates cyclophosphamide-induced diminished ovarian reserve in mouse model. Journal of ethnopharmacology. 208:44–56. https://doi.org/10.1016/j.jep.2017.06.022
crossref pmid

31. Sun Y, Chen S, Tan Y. 2018; Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 43:10. 1068–1074. https://doi.org/10.11817/j.issn.1672-7347.2018.10.005


32. Hung YC, Kao CW, Lin CC, Liao YN, Wu BY, Hung IL, Hu WL. 2016; Chinese herbal products for female infertility in Taiwan: a population-based cohort study. Medicine. 95:11.
crossref

33. Kim DI, Choi MS, Pak SC, Lee SB, Jeon S. 2012; The effects of Sutaehwan-Gami on menopausal symptoms induced by ovariectomy in rats. BMC complementary and alternative medicine. 12:227 https://doi.org/10.1186/1472-6882-12-227
crossref pmid pmc

34. Ke J, Duan R. 2013; Effects of flavonoids from semen cuscutae on the hippocampal -hypothalamic-pituitary-ovarian sex hormone receptors in female rats exposed to psychological stress. Clinical and experimental obstetrics & gynecology. 40:2. 271–274.
pmid

35. Liu C, Liu LH, Li N, Xiu A, Zhang Z, Ai H. 2021; Efficacy of an Yinyanghuo (Herba Epimedii Brevicornus)-Xianmao (Rhizoma Curculiginis) drug pair in a rat model of polycystic ovary syndrome. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 41:4. 588–599. https://doi.org/10.19852/j.cnki.jtcm.2021.03.011
pmid

Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953.journal@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI